Xue, Z., Qie, Y., Li, X., Liang, S., Zhao, J., Li, L., Chen, H., Lin, Y., Han, G., Shen, C., Wu, Z., Hu, H. (2026). Cost-effectiveness analysis in the era of systemic immunotherapy for BCG-naive high-risk non–muscle-invasive bladder cancer in the United States, the United Kingdom, and China.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4598